Hormone

Else Nutrition Announces Highly Anticipated First Commercial Launch of its Groundbreaking Plant-Based Infant Formula in Australia; Also Targeting $50B (USD) Plus Asia Pacific Baby & Child Nutrition Markets

Retrieved on: 
Tuesday, April 2, 2024
Solvent, Dicarboxylic acid, Pesticide, Hormone, Nutrient, Entrepreneurship, BABY, Fats, Sale, Infant, Carbohydrate, Phytoestrogen, Carbon, Protein, Parent, Genetically modified organism, Allergen, Dietary supplement

VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”) is proud to announce the official commercial launch of its first-in-class ‘Follow-On’ formula for infants ages 6-12 months in Australia. The commercial launch of the Follow-On formula for infants in Australia is a significant milestone as it marks the first country, along with New Zealand, in which the Company’s new infant formula is eligible for sale. In addition, the Company announces the launch of its Toddler Drink for toddlers ages 12-36 months in Australia.

Key Points: 
  • In addition, the Company announces the launch of its Toddler Drink for toddlers ages 12-36 months in Australia.
  • According to Research and Markets , the Asia Pacific (APAC) baby, infant and toddler food market is expected to grow from an estimated market size of US$50 billion in 2021 to over US$75 billion in 2028.
  • Else's plant-based infant formula also addresses consumer concerns about processed ingredients, major allergens, and potential residues found in standard dairy-based formulas.
  • Else’s infant formula is free of antibiotics, hormones, pesticides, GMOs, and heavy metals – all of which are an increasing concern among parents.

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

Retrieved on: 
Thursday, March 28, 2024
Cream, Dysmenorrhea, Patient, History, Bacteria, G&A, Vaginal discharge, IND, Bayer, Human development, Investment, Diclofenac, NSAID, Menstruation, Research, Hormone, Bacterial vaginosis, P-value, Webcast, SAN, NIH, Trial of the century, Pleasure, Woman, Breast cancer, Safety, Pharmacokinetics, Food, Development, Menopause, Nonsteroidal anti-inflammatory drug, HR, ARPA, VVA, Tamoxifen, FDA, Attention, CRADA, Female, Dyspareunia, Ecosystem, NICHD, Bangladesh Technical Education Board

SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2023 and provided a company update.

Key Points: 
  • In addition, we are excited about the increased attention that women’s health has received more broadly,” said Sabrina Martucci Johnson, President and CEO of Daré Bioscience.
  • In December 2023, Daré announced positive topline results from the Phase 1 study evaluating the pharmacokinetics (PK), safety, and exploratory efficacy of DARE-PDM1.
  • Financial Highlights for the Year Ended December 31, 2023 and 2024 Projections
    Cash and cash equivalents: $10.5 million at December 31, 2023.
  • Daré will host a conference call and live webcast today, March 28, 2024, at 4:30 p.m. Eastern Time to review financial results for the year ended December 31, 2023 and to provide a company update.

RC Show 2024 Release New & Innovative Product Showcase

Retrieved on: 
Wednesday, March 27, 2024
Cooking, LFC, PFAS, Milk, Pineapple, Enercare Centre, Carbon, Wine, Pea, Restaurant, Creativity, Marketing, Automation, Red meat, Ginger, Drink, Miski, Hormone, VKD, Atlas, Freezing, Notch, Woman, Mouth, Safety, Interim, Cholesterol, Sambucus, Breakfast, Food, Rejuvenation, Taste, Bison, Coffee, RC, Plant, Food safety, Advertising, Farmer, Growth, ServiceNow, SoFi, Environment, Agave, Robotics, Water, Billio, MEIKO, AMT, Genetically modified organism, Tractor

Since 2010, KEENON Robotics , driven by its slogan "Keen on robots, keen on the future," has led the robotics sector.

Key Points: 
  • Since 2010, KEENON Robotics , driven by its slogan "Keen on robots, keen on the future," has led the robotics sector.
  • With a comprehensive range including advertising, delivery, hotel, and the latest addition, cleaning robots, they cater to diverse commercial needs.
  • Diversey Canada Inc. has been a pivotal player in increasing operational efficiency for the industry and that continues in 2024.
  • You will find more of these innovative products and solutions all under one roof at RC Show 2024, taking place April 8-10, where the industry will come together, be inspired and learn how to LEVEL UP!

Corti Set to Disrupt the Health Wearable Market with the First Real-time, Continuous Monitor for Cortisol and Melatonin Hormones, the Key Stress and Sleep Hormones

Retrieved on: 
Thursday, April 4, 2024
Wearables, Mobile Technology, Technology, Mental Health, Fitness & Nutrition, Health Technology, Other Health, Health, General Health, Consumer Electronics, Moses Austin, Benchmarking, Hormone, Exercise, Professor, Inflammation, Biomarker, Research, Sleep, Melatonin, University, Doctor of Philosophy, Life, Eye, Diet, Management, Publication, Skin, Cortisol, Ageing, Medical device

The wearable features its proprietary passive-sweat sensor technology that non-invasively rests on your skin, day and night, continuously measuring biomarker levels.

Key Points: 
  • The wearable features its proprietary passive-sweat sensor technology that non-invasively rests on your skin, day and night, continuously measuring biomarker levels.
  • Now, it provides users with unmatched real-time insights into their wellness, establishing a new benchmark for the continuous monitoring of these critical biomarkers.
  • Corti redefines health monitoring by offering continuous, real-time visibility into the body's key stress and sleep hormones, Cortisol and Melatonin, marking a first in the wearable market.
  • Moreover, we are actively working with partnering businesses to discover new applications, enhancing its integration into various health and wellness ecosystems.

IASO Bio Announces U.S. FDA Approval of Investigational New Drug Application for BCMA CAR-T Equecabtagene Autoleucel for Generalized Myasthenia Gravis

Retrieved on: 
Thursday, April 4, 2024
Vital capacity, MuSK protein, Glucocorticoid, NMPA, Hormone, GMG, Disease, Chinese, MRS, BCMA, Nervous system, Patient, SAN, Enzyme inhibitor, History, Female, Multiple myeloma, CRS, B cell, Biotechnology, IND, Phenotype, Investigational New Drug, QMG, Safety, Thymectomy, FDA, Food

The Chinese IND for this indication of Equecabtagene Autoleucel was approved by the NMPA in January this year.

Key Points: 
  • The Chinese IND for this indication of Equecabtagene Autoleucel was approved by the NMPA in January this year.
  • The 2 subjects were treated with a single infusion of Eque-cel at the doses of 1.0×106 CAR-T/Kg, respectively.
  • No immunomodulatory therapy other than low dose pyridostigmine (90 mg/day and 60 mg/day, respectively) was used during the follow-up period.
  • Anti-AChR antibodies, anti-Titin antibodies, and anti-MuSK antibodies decreased rapidly and maintained at very low levels in both subjects after infusion.

Prevent Blindness Provides Free Resources as Part of April's Women's Eye Health and Safety Month to Educate Women on Necessary Steps to Help Save Sight

Retrieved on: 
Wednesday, March 27, 2024
Orbis, IOP, Pigment, Glaucoma, Le Bonheur Children's Hospital, Social media, Pressure, Visual impairment, Contact, Paratriathlon, Intraocular pressure, AAO, Policy, Orbis International, Hormone, Diabetes, Risk, Mental health, Delta Gamma, NIH, Eyelid, Prevalence, Eye, Associate, Safety, Cataract, Menopause, University, Pregnancy, Hospital, Melasma, Public health, Lactation, Puberty, American Academy, Lens, Telecanthus, Eye disease, Graves' ophthalmopathy, Bangladesh Technical Education Board, Dry eye syndrome, Pediatrics, Birth control

CHICAGO, March 27, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading nonprofit eye health organization, has declared April as Women's Eye Health and Safety Month. According to Orbis International, globally there are 112 million more women than men living with vision loss, including blindness. Prevent Blindness is offering free resources, including fact sheets, shareable social media graphics, educational videos and web pages, on a range of eye health issues that predominantly affect women.

Key Points: 
  • CHICAGO, March 27, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's leading nonprofit eye health organization, has declared April as Women's Eye Health and Safety Month.
  • Prevent Blindness is offering free resources, including fact sheets, shareable social media graphics, educational videos and web pages, on a range of eye health issues that predominantly affect women.
  • Women have a higher prevalence of age-related macular degeneration, cataract, dry eye, glaucoma, refractive error and thyroid eye disease.
  • For more information on women's eye health topics, including fact sheets on eye diseases and eye safety, please visit PreventBlindness.org.

KINDRA LAUNCHES FIRST-EVER COMPREHENSIVE VAGINAL HEALTH SYSTEM: THE DAILY V SYSTEM

Retrieved on: 
Monday, March 25, 2024
DPT, Testosterone, Sulfate, Urology, Hormone, Hyaluronic acid, Woman, Vaginal lubrication, FACOG, Libido, Arousal, Paraben, Dry, MD, Itch, Vaginitis, WCS, Skin, Pelvic floor, Stinger, Irritation, Medicine, Personal lubricant, Pain, BCB-PMD, Orgasm, Birth control

NEW YORK, March 25, 2024 /PRNewswire/ -- Today, Kindra, the sex-positive vaginal health brand, announced the launch of the first-ever comprehensive vaginal health product system - the Daily V System. The 4-part daily regimen of Kindra products includes: Daily Vaginal Lotion, V Relief Serum, Soothe Bath Soak and the Core Supplement meant to support vulvar and vaginal skin for optimal vaginal health and sexual wellness.

Key Points: 
  • NEW YORK, March 25, 2024 /PRNewswire/ -- Today, Kindra , the sex-positive vaginal health brand, announced the launch of the first-ever comprehensive vaginal health product system - the Daily V System .
  • The 4-part daily regimen of Kindra products includes: Daily Vaginal Lotion , V Relief Serum , Soothe Bath Soak and the Core Supplement meant to support vulvar and vaginal skin for optimal vaginal health and sexual wellness.
  • This hormone-free system is designed to provide targeted relief and support for daily vulvar and vaginal health needs.
  • As part of its launch of the Daily V System, Kindra has partnered with pelvic floor physical therapist Dr. Sara Reardon, known online as The Vagina Whisperer, on a video about the importance of a daily vaginal health regimen for long-term vulvovaginal health and comfort.

Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal

Retrieved on: 
Wednesday, March 20, 2024
California Department, Hormone, SAN, Lactic acid, Prescription, Medicaid, OTCQB, FDA, Citric acid, Medi-Cal, Birth control

SAN DIEGO, March 20, 2024 /PRNewswire/ -- Commercial-stage women's health innovator Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced that it has successfully renegotiated the rebate for Phexxi® (lactic acid, citric acid and potassium bitartrate), its hormone-free, woman-controlled contraceptive, with Medi-Cal, the California state Medicaid program.

Key Points: 
  • Phexxi is the first and only locally-acting contraceptive gel approved by the FDA.
  • It is applied zero-to-60 minutes before intercourse and works, without hormones, by maintaining the natural vaginal biome with a pH that is naturally inhospitable to sperm.
  • The renegotiated rebate improves Evofem's rebate on Medi-Cal prescriptions by 7.4%, while affording price protection to Medi-Cal against future Phexxi WAC increases.
  • Medi-Cal beneficiaries may receive one box of 12 single-use Phexxi applicators per dispensing, and up to three boxes in any 75-day period.

New Research Continues to Support Massage Therapy for Improving Sleep Quality

Retrieved on: 
Tuesday, March 19, 2024
EEG, Pregnancy, Health, Brain, Hormone, Facial muscles, Blood, Insomnia, Research, Sleep, Menopause, Therapeutic touch, Anxiety, Massage, Woman, CDC, System, Heart, Pre-eclampsia, AMTA, Fatigue, Swelling, Pharmaceutical industry

EVANSTON, Ill., March 19, 2024 /PRNewswire/ -- It's National Sleep Awareness Month, and the American Massage Therapy Association (AMTA) is sharing the latest research on how massage can improve sleep quality.

Key Points: 
  • EVANSTON, Ill., March 19, 2024 /PRNewswire/ -- It's National Sleep Awareness Month, and the American Massage Therapy Association (AMTA) is sharing the latest research on how massage can improve sleep quality.
  • AMTA is sharing the latest research on how massage therapy can help improve sleep quality for women and infants.
  • Results revealed that therapeutic touch significantly improved sleep quality compared to the control group, as indicated by lower post-test total sleep quality scores.4
    "The evidence continues to grow on the efficacy of massage therapy for improving sleep quality," said Kim Kane-Santos, AMTA National President.
  • 5 For millions of restless Americans, massage therapy may lead to a better night's sleep.

BLACK SKULL LAUNCHES AT A FAIR IN CALIFORNIA A POST-WORKOUT WITH EXCLUSIVE SALE ON AMAZON

Retrieved on: 
Friday, March 15, 2024
Health, GROW, Stevia, University, Hormone, Islam, Sport, Amazon, Lactose, Antibody, GMO, Colostrum, GDS, Hypertrophy, Quality of life, Jews, Diet, Investment, Water, Oligosaccharide, WHEY, Multimedia, BLACK, Soil, Food safety, Chocolate, Allergen, Dairy

SÃO PAULO, March 14, 2024 /PRNewswire/ -- BLACK SKULL (www.blackskullusa.com), a brand from Grow Dietary Supplements Labs USA (GDS), a leader in the hardcore nutrition segment in Brazil, participates in the largest fair in the world in the natural sector, the Natural Products Expo West, which takes place from March 12th to 16th, in Anaheim, California – USA. The brand will present its newest launch, WHEY GRASS FED, the first post-workout supplement that has 19g of high biological value protein and 1g of Bovine Colostrum, which will be sold exclusively on the AMAZON platform, initially for the North American market.

Key Points: 
  • The supplement is Halal and Kosher certified and will be presented at Natural Products Expo West.
  • Colostrum is composed of a powerful combination of bioactives (immunoglobulins, immune modulators and oligosaccharides), which support immunological, respiratory and intestinal health.
  • The product arrives in sustainable 900-gram packaging, with freeze-dried natural smell from the Amazon, such as Guaraná with Açaí and Chocolate with Cupuaçu.
  • "In addition to contributing to the health of consumers, WHEY GRASS FED will help fruit producer cooperatives in the Amazon and riverside families.